Giroux E, Vargaftig B B
Biochim Biophys Acta. 1978 Aug 7;525(2):429-37. doi: 10.1016/0005-2744(78)90239-5.
Clostridiopeptidase B (EC 3.4.22.8) was not inhibited by stoichiometric amounts of lima bean trypsin inhibitor, ovomucoid trypsin inhibitor, Kuntiz bovine trypsin inhibotor, Kunitz soybean trypsin inhibitor or ovoinhibitor. Activity was diminished at relatively high concentrations of the three latter inhibitors. Human plasma alpha 2-macroglobulin inhibited both the amidase and protease activity of the enzyme. Rat and dog plasmas contained high molecular weight inhibitors, presumably macroglobulins as well. Inhibition by this component was greater in rat plasma than in dog plasma, which may be related to the observation that clostridiopeptidase B-induced generation of kinin activity is indirect in the former plasma, but direct in the later. Leupeptin (N-acetyl-L-leucyl-L-leucyl-L-argininal) and antipain ([S)-1-carboxy-2-phenylethyl] carbamoyl-L-arginyl-L-valyl-L-argininal) inhibited clostridiopeptidase B (Ki of 2 . 10(-8) and 3 . 10(-8) M, respectively). They were potent inhibitors of clostridiopeptidase B-induced kinin release in dog plasma.
梭菌肽酶B(EC 3.4.22.8)不会被化学计量的利马豆胰蛋白酶抑制剂、卵类粘蛋白胰蛋白酶抑制剂、昆茨牛胰蛋白酶抑制剂、昆茨大豆胰蛋白酶抑制剂或卵抑制剂所抑制。后三种抑制剂在相对高浓度时会使该酶的活性降低。人血浆α2 -巨球蛋白可抑制该酶的酰胺酶和蛋白酶活性。大鼠和犬的血浆中也含有高分子量抑制剂,推测也是巨球蛋白。该成分在大鼠血浆中的抑制作用比在犬血浆中更强,这可能与以下观察结果有关:在前者血浆中,梭菌肽酶B诱导激肽活性的产生是间接的,而在后者血浆中是直接的。亮抑蛋白酶肽(N - 乙酰 - L - 亮氨酰 - L - 亮氨酰 - L - 精氨醛)和抗蛋白酶([(S)-1 - 羧基 - 2 - 苯乙基]氨基甲酰 - L - 精氨酰 - L - 缬氨酰 - L - 精氨醛)可抑制梭菌肽酶B(Ki分别为2×10⁻⁸和3×10⁻⁸ M)。它们是犬血浆中梭菌肽酶B诱导激肽释放的强效抑制剂。